According to Spero Therapeutics's latest financial reports the company's current revenue (TTM ) is โน3.06 Billion. In 2024 the company made a revenue of โน2.35 Billion a decrease over the revenue in the year 2023 that were of โน8.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.